Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals

• Main Authors: Jiamsakul A., Chaiwarith R., Durier N., Sirivichayakul S., Kiertiburanakul S., Van Den Eede P., Ditangco R., Kamarulzaman A., Li P., Ratanasuwan W., Sirisanthana T., Lee M., Kumarasamy N., Saghayam S., Pujari S., Joshi K., Merati T., Yuliana F., Lee C., Sim B., Ong L., Mustafa M., Nordin N., Bantique R., Chen Y., Lin Y., Phanuphak P., Sungkanuparph S., Chumla L., Sanmeema N., Praparattanapan J., Kantipong P., Kambua P., Sriondee R., Kantor R., Sohn A., Singtoroj T., Cooper D., Law M., Boettiger D.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84954399287&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42133
• Institution: Chiang Mai University

© 2016 Wiley Periodicals, Inc. HIV drug resistance assessments and interpretations can be obtained from genotyping (GT), virtual phenotyping (VP) and laboratory-based phenotyping (PT). We compared resistance calls obtained from GT and VP with those from PT (GT-PT and VP-PT) among CRF01_AE and subtyp...